Article
Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
The Journal of antimicrobial chemotherapy - 1 Apr 2003
Sáenz Yolanda, Zarazaga Myriam, Briñas Laura, Ruiz-Larrea Fernanda, Torres Carmen
Abstract excerpt
Mutations in quinolone targets were analysed in 80 unrelated nalidixic acid-resistant (NALR) Escherichia coli strains whose nalidixic acid and ciprofloxacin MICs ranged from 32 to >256 mg/L and 0.03-64 mg/L, respectively. These strains were isolated from food products (23) and faecal samples from humans (15) and healthy animals (42). Thirteen nalidixic acid-susceptible (NALS) E. coli strains were also analysed....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
